For the first time, the export of corona vaccines from the European Union to a third country has been stopped. Italy prevented the delivery of 250,000 doses of vaccine from the British-Swedish manufacturer AstraZeneca to Australia, as EU circles confirmed on Thursday. At first she had Financial Times reported about it.
The basis is an export control system introduced at the end of January. According to this, pharmaceutical companies that have delivery obligations for the EU must apply for export permits for vaccines produced in the EU. If manufacturers unlawfully disadvantage the EU in terms of delivery quantities, permits could be refused. AstraZeneca had drastically reduced the contractually agreed delivery volume to the EU in the first quarter and thus caused great resentment.
Exports to a number of partner countries and developing countries are excluded from the system. The partner countries include Switzerland, Israel and Ukraine – but not Great Britain and Canada. The EU member state in which the vaccines intended for export were produced is responsible for the export permits. The EU states obtain the opinion of the EU Commission before making any decisions.
In the present case, Rome and Brussels were in agreement according to dpa information. A number of other export applications from other companies had previously been approved, most of them from Biontech / Pfizer, which supplies many countries from Europe.